PBRM1 and cancer: Although previous studies have reported the possible association of PBRM1 with immune response (Zhou et al., 2020; Aili et al., 2021; Yang et al., 2021; Saiga et al., 2022), the specific role of PBRM1 in the pan-cancer with immunotherapy remains not thoroughly confirmed.